This study aimed to determine CCL19/MIP3beta(β) and CCL20/MIP3alpha(α) in the gingival crevicular fluid (GCF) of the patients with different periodontitis phenotypes. A total of 72 individuals, 24 with Stage III Grade B periodontitis (Group 1), 24 with Stage III Grade C periodontitis (Group 2), and 24 periodontally healthy (control group) (Group 3), were included in the study. GCF and clinical periodontal parameters were obtained at baseline. MIP3β and MIP3α levels in GCF were determined by ELISA.
Study Type
OBSERVATIONAL
Enrollment
72
In all of the patients, the following indexes were used routinely for the periodontal examination: Sillness-Löe's plaque index (PI) (Silness \& Löe, 1964), Löe-Sillness's gingival index (GI)(Löe \& Silness, 1963), probing depth (PD) to measure the extent and severity of periodontal disease, clinical attachment level (CAL), and bleeding on probing (BOP)(Ainamo \& Bay, 1975) to determine activity. In addition, routine radiographic evaluations were performed to determine bone levels.GCF samples were collected using standardized filter papers.
Ordu University, Faculty of Dentistry
Ordu, Turkey (Türkiye)
CCL19/MIP3beta(β) levels
CCL19/MIP3beta(β) levels in the gingival crevicular fluid (GCF) of the all groups
Time frame: Baseline
CCL20/MIP3alpha(α) levels
CCL20/MIP3alpha(α) levels in the gingival crevicular fluid (GCF)
Time frame: Baseline
CCL19/MIP3beta(β) levels and clinical parameters
Correlation between CCL19/MIP3beta(β) levels in the gingival crevicular fluid (GCF) of the all groups and all clinical parameters
Time frame: Baseline
CCL20/MIP3alpha(α) levels and clinical parameters
Correlation between CCL20/MIP3alpha(α) levels in the gingival crevicular fluid (GCF) of the all groups and all clinical parameters
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.